Indications |
Oral Allergic conditions Adult: 2.5 mg every 4-6 hr. Max: 10 mg daily. Child: 4 mth-<2 yr: 0.313 mg every 4-6 hr; max: 1.252 mg daily. 2-<4 yr: 0.625 mg every 4-6 hr; max: 2.5 mg daily. 4-<6 yr: 0.938 mg every 4-6 hr; max: 3.744 mg daily. 6-<12 yr: 1.25 mg every 4-6 hr; max: 5 mg daily. ≥12 yr: 2.5 mg every 4-6 hr; max: 10 mg daily. |
Contraindications |
Hypersensitivity to acrivastine; child < 4 mth; lactation. |
Warnings / Precautions |
Angle-closure glaucoma; urinary retention; prostatic hypertrophy; pyloroduodenal obstruction; epilepsy. May impair ability to drive or operate machinery. Broken or eczematous skin (topical use). Child <6 yr should take only under the direction of a physician. Elderly, pregnancy. |
Adverse Reactions |
CNS depression, headache, psychomotor impairment, dry mouth, thickened respiratory tract secretions, blurred vision, urinary difficulty or retention, constipation, increased gastric reflux, nausea, vomiting, diarrhoea, epigastric pain, myalgia, paraesthesias, extrapyramidal effects, tremor, sleep disturbances, depression, confusion, tinnitus, hypotension and hair loss. Potentially Fatal: Blood dyscrasias. |
Overdose Reactions |
Symptoms: Antimuscarinic, extrapyramidal and CNS side effects. In children or elderly, very often, CNS stimulation predominates over CNS depression and causes ataxia, excitement, tremors, psychoses, hallucinations, convulsions, hyperpyrexia, cardiorespiratory collapse and coma. In adults, CNS depression predominates and results in drowsiness, coma, convulsions, respiratory failure and CV collapse. |
Drug Interactions |
Increased sedation with CNS depressants eg, alcohol, barbiturates, hypnotics, opioid analgesics, anxiolytics, sedatives and antipsychotics. Increased antimuscarinic side effects with other antimuscarinic drugs e.g. atropine, TCA and MAOI. May mask signs of ototoxicity caused by aminoglycosides. See Below for More triprolidine hydrochloride Drug Interactions |
Mechanism of Actions |
Triprolidine is an antihistamine derived from alkylamine that has antimuscarinic and mild sedative effects. May also be used in fixed dose combination with pseudoephedrine hydrochloride. Distribution: Distributed into breast milk. Metabolism: A carboxylated derivative makes up about half of the dose excreted in the urine. Excretion: Excreted via urine as metabolites. Reported half life: 3-5 hr or more. |
Administration |
May be taken with or without food. |
Storage Conditions |
Oral: Store between 15-30°C. |
ATC Classification |
R06AX07 - triprolidine ; Belongs to the class of other antihistamines for systemic use. |
Storage |
Oral: Store between 15-30°C. |
Available As |
|
Triprolidine
Post Review about Triprolidine Click here to cancel reply.
Triprolidine Containing Brands
Triprolidine is used in following diseases
Drug - Drug Interactions of Triprolidine
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.